Heparin-induced Thrombocytopenia: A known rare complication of heparin therapy
Author(s) -
Nissar Shaikh,
M. Ataur Rahman,
Mohammed Nayeemuddin,
I. N. Maudali,
Matthias Rief,
Hassan Al Thani
Publication year - 2012
Publication title -
qatar medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.171
H-Index - 9
eISSN - 2227-0426
pISSN - 0253-8253
DOI - 10.5339/qmj.2012.1.21
Subject(s) - medicine , heparin induced thrombocytopenia , heparin , intensivist , complication , intensive care medicine , platelet , pathological , surgery , intensive care unit
Heparin-induced thrombocytopenia (HIT) is a rare clinico-pathological abnormality. It is characterized by the development of thrombocytopenia, resulting from heparin administration, which leads to a decrease in platelet count by 50%, or to less than 1 0 0 x 1 0 3 M within 5 to 14 days. HIT causes increased morbidity and mortality, thus it is of vital importance that acute care physicians, surgeons and intensivist should be aware of this clinical entity. We report a case of heparin-induced thrombocytopenia and review of its management, including alternatives to heparin therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom